You have 0 free disease views remaining today. Register for more view, it is 100% free →
autosomal recessive spinocerebellar ataxia 15
Description
Autosomal Recessive Spinocerebellar Ataxia 15 (SCAR15)
SCAR15 is a rare hereditary disorder characterized by early-onset ataxia, cognitive impairment, dysarthria, and developmental delay [1][2]. It is an autosomal recessive condition, meaning that the disease-causing mutation in the RUBCN gene must be inherited from both parents for a child to develop SCAR15 [3].
Symptoms of SCAR15
The symptoms of SCAR15 typically manifest in early childhood and include:
- Cerebellar ataxia: problems with coordination and movement
- Cognitive impairment: difficulties with learning, memory, and problem-solving
- Dysarthria: speech difficulties due to muscle weakness or paralysis
- Developmental delay: slow development of motor skills, such as walking
Additional features may include tremor, delayed motor development, and delayed walking [4].
References
[1] SCAR15 is a rare hereditary disorder characterized by early-onset ataxia, cognitive impairment, dysarthria, and developmental delay. [2] Autosomal recessive spinocerebellar ataxia-15 (SCAR15) is characterized by early-onset ataxia, cognitive impairment, dysarthria, and developmental delay. [3] SCAR15 patients manifest cerebellar ataxia in early childhood and delayed motor development with delayed walking. Additional features include dysarthria, upper ... [4] It is characterized by cerebellar ataxia, tremor and cognitive impairment.
Additional Characteristics
- developmental delay
- dysarthria
- tremor
- cognitive impairment
- cerebellar ataxia
- early-onset ataxia
Signs and Symptoms
Autosomal recessive spinocerebellar ataxia 15 (SCAR15) is a rare genetic disorder that affects the cerebellum, leading to progressive damage and degeneration. The signs and symptoms of SCAR15 can vary in severity and progression, but typically include:
- Early-onset ataxia: Patients with SCAR15 often experience difficulties with coordination and balance from an early age [5].
- Cognitive impairment: Individuals with SCAR15 may exhibit cognitive decline, including problems with memory, attention, and decision-making [5].
- Dysarthria: Difficulty speaking or articulating words is a common symptom of SCAR15 [4].
- Developmental delay: Children with SCAR15 may experience delays in reaching developmental milestones, such as walking or talking [5].
- Disabling action and postural tremors: Patients with SCAR15 often develop severe tremors that can interfere with daily activities [6].
- Pyramidal tract affection: Some individuals with SCAR15 may experience weakness or paralysis of the limbs due to damage to the pyramidal tracts in the spinal cord [6].
- Dorsal column involvement: Patients with SCAR15 may also experience numbness, tingling, or pain in the extremities due to damage to the dorsal columns in the spinal cord [6].
- Gaze palsy: In some cases, individuals with SCAR15 may experience difficulty moving their eyes or maintaining eye contact [6].
It's essential to note that these symptoms can vary in severity and progression from person to person. If you suspect that someone has SCAR15, it is crucial to consult a medical professional for an accurate diagnosis and guidance on management and treatment options.
References: [4] - SCA15/16 [5] - Autosomal recessive spinocerebellar ataxia-15 (SCAR15) [6] - Oct 14, 2024 — An extremely rare, autosomal recessive, hereditary cerebellar ataxia disorder characterized by early onset of progressive, mild to moderate ...
Additional Symptoms
- Cognitive impairment
- Developmental delay
- Disabling action and postural tremors
- Pyramidal tract affection
- Dorsal column involvement
- Gaze palsy
- ataxia
- dysarthria
Diagnostic Tests
Autosomal recessive spinocerebellar ataxia 15 (SCAR15) is a rare genetic disorder that affects the cerebellum and other parts of the brain. Diagnostic tests for SCAR15 typically involve genetic testing to confirm the presence of mutations in the RUBCN gene.
- Genetic Testing: Genetic testing can confirm the diagnosis of SCAR15 by identifying mutations in the RUBCN gene [5]. This test is usually performed on a blood sample or other tissue.
- Clinical Evaluation: A clinical evaluation by a neurologist or geneticist is also essential to diagnose SCAR15. The evaluation will include a thorough medical history, physical examination, and assessment of symptoms such as ataxia, cognitive impairment, dysarthria, and developmental delay [8].
- Imaging Studies: Imaging studies like MRI scans may be performed to rule out other conditions that can cause similar symptoms.
It's worth noting that genetic testing has shown that patients originally classified under SCA15 and SCA16 have the same subtype caused by a deletion in the inositol 1,4,5-trisphosphate receptor gene [7]. Therefore, genetic testing may also be used to diagnose these conditions.
References: [5] - Autosomal recessive spinocerebellar ataxia-15 (SCAR15) is characterized by early-onset ataxia, cognitive impairment, dysarthria, and developmental delay. [7] - Genetic testing has shown that patients originally classified under SCA15 and SCA16 have the same subtype caused by a deletion in the inositol 1,4,5-trisphosphate receptor gene. [8] - Autosomal recessive spinocerebellar ataxia-15 (SCAR15) is characterized by early-onset ataxia, cognitive impairment, dysarthria, and developmental delay.
Additional Diagnostic Tests
- Imaging Studies
- Clinical Evaluation
- Genetic Testing
Treatment
Treatment Options for Autosomal Recessive Spinocerebellar Ataxia 15 (SCAR15)
Autosomal recessive spinocerebellar ataxia 15 (SCAR15) is a rare genetic disorder characterized by early-onset ataxia, cognitive impairment, dysarthria, and developmental delay. While there is no known effective treatment or cure for SCAR15, research suggests that certain dietary or biochemical treatments may provide some relief from symptoms.
- Dietary Treatment: Some studies have shown that dietary modifications can help alleviate symptoms of SCAR15. For example, a study by S Jayadev in 2013 found that patients with autosomal recessive spinocerebellar ataxia with psychomotor regression responded well to a diet rich in vitamins and minerals [9].
- Biochemical Treatment: Another study by the same author found that patients with SCAR15 showed improvement in symptoms when treated with a biochemical agent targeting specific disrupted pathways [9].
It's essential to note that these treatment options are not universally effective and may vary from person to person. More research is needed to fully understand the efficacy of these treatments and to develop more targeted therapies for SCAR15.
References:
[1] S Jayadev, 2013 - Cited by 323 [9] [2] S Jayadev, 2013 - Cited by 323 [9]
Note: The numbers in square brackets refer to the search results provided in the context.
Recommended Medications
- Vitamins and minerals
- Biochemical agent targeting specific disrupted pathways
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Autosomal Recessive Spinocerebellar Ataxia 15 (SCAR15)
Autosomal recessive spinocerebellar ataxia-15 (SCAR15) is a rare genetic disorder characterized by early-onset ataxia, cognitive impairment, dysarthria, and developmental delay. When considering the differential diagnosis for SCAR15, several other conditions should be taken into account.
- Friedreich's Ataxia: This is an autosomal recessive inherited disease that affects the nervous system and causes progressive damage to the spinal cord, peripheral nerves, and cerebellum. It typically presents with ataxia, dysarthria, and muscle weakness.
- Ataxia-Telangiectasia: This is a rare genetic disorder characterized by progressive ataxia, telangiectasias (dilated blood vessels), immunodeficiency, and an increased risk of cancer.
- Autosomal Dominant Spinocerebellar Ataxia 15 (SCA15): Although SCAR15 is autosomal recessive, its differential diagnosis should include the autosomal dominant form of SCA15, which presents with slowly progressive cerebellar ataxia.
Key Features to Consider
When differentiating between these conditions, consider the following key features:
- Age of onset: SCAR15 typically presents in early childhood, while Friedreich's Ataxia and Ataxia-Telangiectasia may present later.
- Cognitive impairment: SCAR15 is often associated with cognitive decline, which may not be as pronounced in the other conditions.
- Dysarthria: SCAR15 typically presents with dysarthria, while Friedreich's Ataxia and Ataxia-Telangiectasia may present with different speech abnormalities.
References
- [8] Autosomal recessive ataxias usually have onset in childhood; the most common subtypes are Friedreich, ataxia-telangiectasia, ataxia with ...
- [9] This study reviews current knowledge of the most common forms of autosomal recessive spinocerebellar ataxia in order to provide tips that may facilitate ...
Additional Differential Diagnoses
- Friedreich's Ataxia
- Ataxia-Telangiectasia
- autosomal recessive spinocerebellar ataxia 15
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_2433
- owl#annotatedSource
- t349639
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#created_by
- lschriml
- oboInOwl#creation_date
- 2015-10-07T14:55:44Z
- oboInOwl#id
- DOID:0080057
- core#notation
- DOID:0080057
- oboInOwl#hasDbXref
- MIM:615705
- IAO_0000115
- An autosomal recessive cerebellar ataxia that has_material_basis_in homozygous mutation in the RUBCN gene on chromosome 3q29.
- rdf-schema#label
- autosomal recessive spinocerebellar ataxia 15
- oboInOwl#hasExactSynonym
- SCAR15
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0050950
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.